MYGN - Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27 2024 | Benzinga
SALT LAKE CITY, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, will hold its fourth quarter earnings conference call on Tuesday, February 27, 2024 at 4:30p.m. EST. The company's quarterly earnings will be released the same day after the market closes.
During the call, Myriad management will provide a financial overview and business update of the company's performance for the fourth quarter and full year 2023. Revenue and earnings guidance for 2024 will also be shared.
A live webcast of the earnings conference call can be accessed on Myriad's Investor ...